VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Vaccine Mechanisms
Vaximmutordb
Vaxism
Vaxar
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UMMS Logo

Vaxlert: Peer-reviewed Vaccine Publications in Current Month

From Apr 01, 2014 To Apr 23, 2014:


Bacillus anthracis (Anthrax)

  1. Mangal S, Pawar D, Agrawal U, Jain AK, Vyas SP. Evaluation of mucoadhesive carrier adjuvant: Toward an oral anthrax vaccine Artificial cells, nanomedicine, and biotechnology (Print) 2013 [PMID: 23452384]
  2. Liu J, Cai C, Guo Q, Zhang J, Dong D, Li G, Fu L, Xu J, Chen W. Secretory expression and efficient purification of recombinant anthrax toxin lethal factor with full biological activity in E. coli Protein expression and purification 2013 [PMID: 23459291]

Ebola virus

  1. Dekhtiarenko I, Jarvis MA, Ruzsics Z, Cicin-Sain L. The Context of Gene Expression Defines the Immunodominance Hierarchy of Cytomegalovirus Antigens Journal of immunology (Baltimore, Md. : 1950) 2013 [PMID: 23460738]

Escherichia coli

  1. Merritt JH, Ollis AO, Fisher AC, Delisa MP. Glycans-by-design: Engineering bacteria for the biosynthesis of complex glycans and glycoconjugates Biotechnology and bioengineering 2013 [PMID: 23456823]
  2. Liu J, Cai C, Guo Q, Zhang J, Dong D, Li G, Fu L, Xu J, Chen W. Secretory expression and efficient purification of recombinant anthrax toxin lethal factor with full biological activity in E. coli Protein expression and purification 2013 [PMID: 23459291]
  3. Gupta N, Chakrabarti K, Prakash K, Wadhwa N, Gupta T, Gupta SK. Immunogenicity and Contraceptive Efficacy of Escherichia coli-Expressed Recombinant Porcine Zona Pellucida Proteins American journal of reproductive immunology (New York, N.Y. : 1989) 2013 [PMID: 23444974]

Human immunodeficiency virus (acquired immunodeficiency syndrome)

  1. Vermund SH, Hayes RJ. Combination Prevention: New Hope for Stopping the Epidemic Current HIV/AIDS reports 2013 [PMID: 23456730]
  2. Farrington LA, Smith TA, Grey F, Hill AB, Snyder CM. Competition for Antigen at the Level of the APC Is a Major Determinant of Immunodominance during Memory Inflation in Murine Cytomegalovirus Infection Journal of immunology (Baltimore, Md. : 1950) 2013 [PMID: 23455500]
  3. Li Y, Huang Y, Liang J, Xu Z, Shen Y, Zhang N, Liu Z, Zhao Y. Immune responses induced in HHD mice by multiepitope HIV vaccine based on cryptic epitope modification Molecular biology reports 2013 [PMID: 23456642]
  4. Yan J, Sabbaj S, Bansal A, Amatya N, Shacka JJ, Goepfert PA, Heath SL. HIV specific CD8+ T cells from Elite Controllers are Primed for Survival Journal of virology 2013 [PMID: 23449791]
  5. Chege GK, Burgers WA, Stutz H, Meyers A, Chapman R, Kiravu A, Bunjun R, Shephard EG, Jacobs WR Jr, Rybicki EP, Williamson AL. Robust immunity to an auxotrophic BCG-VLP prime-boost HIV vaccine candidate in a non-human primate model Journal of virology 2013 [PMID: 23449790]
  6. Andrasik MP, Yoon R, Mooney J, Broder G, Bolton M, Votto T, Davis-Vogel A. Exploring Barriers and Facilitators to Participation of Male-to-Female Transgender Persons in Preventive HIV Vaccine Clinical Trials Prevention science : the official journal of the Society for Prevention Research 2013 [PMID: 23446435]
  7. Kanazawa T, Tamura T, Yamazaki M, Takashima Y, Okada H. Needle-free intravaginal DNA vaccination using a stearoyl oligopeptide carrier promotes local gene expression and immune responses International journal of pharmaceutics 2013 [PMID: 23454850]
  8. Koblin BA, Metch B, Novak RM, Morgan C, Lucy D, Dunbar D, Graham P, Swann E, Madenwald T, Escamilia G, Frank I. Feasibility of identifying a cohort of US women at high risk for HIV infection for HIV vaccine efficacy trials: Longitudinal results of HVTN 906 Journal of acquired immune deficiency syndromes (1999) 2013 [PMID: 23446497]
  9. Coleman JS, Mwachari C, Balkus J, Sanguli L, Muliro A, Agnew K, Coombs RW, Cohen CR, Hitti J. Effect of the levonorgestrel intrauterine device on genital HIV-1 RNA shedding among HIV-1-infected women not taking antiretroviral therapy in Nairobi, Kenya Journal of acquired immune deficiency syndromes (1999) 2013 [PMID: 23446496]
  10. Riedmann EM. Human Vaccines & Immunotherapeutics: News Human vaccines & immunotherapeutics 9(2) 2013 [PMID: 23449312]
  11. McIlroy D. Do HIV-specific CTL continue to have an antiviral function during antiretroviral therapy? If not, why not, and what can be done about it? Frontiers in immunology 4:52 2013 [PMID: 23459829]

Mycobacterium tuberculosis (tuberculosis)

  1. Vermund SH, Hayes RJ. Combination Prevention: New Hope for Stopping the Epidemic Current HIV/AIDS reports 2013 [PMID: 23456730]
  2. Osório NS, Rodrigues F, Gagneux S, Pedrosa J, Pinto-Carbó M, Castro AG, Young D, Comas I, Saraiva M. Evidence for diversifying selection in a set of Mycobacterium tuberculosis genes in response to antibiotic and non-antibiotic related pressure Molecular biology and evolution 2013 [PMID: 23449927]
  3. White AD, Sibley L, Dennis MJ, Gooch K, Betts G, Edwards N, Reyes-Sandoval A, Carroll MW, Williams A, Marsh PD, McShane H, Sharpe SA. An evaluation of the safety and immunogenicity of a candidate TB vaccine, MVA85A, delivered by aerosol to the lungs of macaques Clinical and vaccine immunology : CVI 2013 [PMID: 23446219]
  4. Ocampo M, Patarroyo MA, Vanegas M, Alba MP, Patarroyo ME. Functional, biochemical and 3D studies of Mycobacterium tuberculosis protein peptides for an effective anti-tuberculosis vaccine Critical reviews in microbiology 2013 [PMID: 23445450]

Plasmodium falciparum (Malaria)

  1. Cheng Y, Wang Y, Ito D, Kong DH, Ha KS, Chen JH, Lu F, Li J, Wang B, Takashima E, Sattabongkot J, Tsuboi T, Han ET. PvMSP1P, merozoite surface protein 1 paralog, is a novel erythrocyte-binding ligand of Plasmodium vivax Infection and immunity 2013 [PMID: 23460511]
  2. Fricke J, Pohlmann K, Jonescheit NA, Ellert A, Joksch B, Luttmann R. Designing a fully automated multi-bioreactor plant for fast DoE-optimization of pharmaceutical protein production Biotechnology journal 2013 [PMID: 23447434]
  3. Moorthy V, Newman R, Duclos P, Okwo-Bele J, Smith P. Assessment of the RTS,S/AS01 malaria vaccine The Lancet infectious diseases 2013 [PMID: 23454165]
  4. Bejon P, White MT, Olotu A, Bojang K, Lusingu JP, Salim N, Otsyula NN, Agnandji ST, Asante KP, Owusu-Agyei S, Abdulla S, Ghani AC. Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data The Lancet infectious diseases 2013 [PMID: 23454164]
  5. Heppner DG. The malaria vaccine - Status quo 2013 Travel medicine and infectious disease 2013 [PMID: 23454205]
  6. Bitencourt AR, Vicentin EC, Jimenez MC, Ricci R, Leite JA, Costa FT, Ferreira LC, Russell B, Nosten F, Rénia L, Galinski MR, Barnwell JW, Rodrigues MM, Soares IS. Antigenicity and Immunogenicity of Plasmodium vivax Merozoite Surface Protein-3 PloS one 8(2):e56061 2013 [PMID: 23457498]
  7. Chuang I, Sedegah M, Cicatelli S, Spring M, Polhemus M, Tamminga C, Patterson N, Guerrero M, Bennett JW, McGrath S, Ganeshan H, Belmonte M, Farooq F, Abot E, Banania JG, Huang J, Newcomer R, Rein L, Litilit D, Richie NO, Wood C, Murphy J, Sauerwein R, Hermsen CC, McCoy AJ, Kamau E, Cummings J, Komisar J, Sutamihardja A, Shi M, Epstein JE, Maiolatesi S, Tosh D, Limbach K, Angov E, Bergmann-Leitner E, Bruder JT, Doolan DL, King CR, Carucci D, Dutta S, Soisson L, Diggs C, Hollingdale MR, Ockenhouse CF, Richie TL. DNA Prime/Adenovirus Boost Malaria Vaccine Encoding P. falciparum CSP and AMA1 Induces Sterile Protection Associated with Cell-Mediated Immunity PloS one 8(2):e55571 2013 [PMID: 23457473]
  8. Planson AG, Guijarro JI, Chaffotte AF. New Insights for Native Production of MSP119, the Disulfide-Rich C-Terminal Fragment from Plasmodium falciparum Merozoite Surface Protein 1 PloS one 8(2):e57086 2013 [PMID: 23451153]

Salmonella

  1. Riedmann EM. Human Vaccines & Immunotherapeutics: News Human vaccines & immunotherapeutics 9(2) 2013 [PMID: 23449312]

Variola major (Smallpox)

  1. . Secondary and tertiary transmission of vaccinia virus after sexual contact with a smallpox vaccinee - san diego, california, 2012 MMWR. Morbidity and mortality weekly report 62:145-147 2013 [PMID: 23446513]
  2. Mizumoto K, Ejima K, Yamamoto T, Nishiura H. Vaccination and clinical severity: is the effectiveness of contact tracing and case isolation hampered by past vaccination? International journal of environmental research and public health 10(3):816-829 2013 [PMID: 23446821]
  3. Kightlinger L. Vaccine-preventable diseases and vaccination rates in South Dakota South Dakota medicine : the journal of the South Dakota State Medical Association Spec no:84-89 2013 [PMID: 23444597]
  4. Hsu JL. A brief history of vaccines: smallpox to the present South Dakota medicine : the journal of the South Dakota State Medical Association Spec no:33-37 2013 [PMID: 23444589]
  5. Hoffman WW. The case for vaccines South Dakota medicine : the journal of the South Dakota State Medical Association Spec no:10-16 2013 [PMID: 23444585]

Vibrio cholerae

  1. Marin MA, Thompson CC, Freitas FS, Fonseca EL, Aboderin AO, Zailani SB, Quartey NK, Okeke IN, Vicente AC. Cholera Outbreaks in Nigeria Are Associated with Multidrug Resistant Atypical El Tor and Non-O1/Non-O139 Vibrio cholerae PLoS neglected tropical diseases 7(2):e2049 2013 [PMID: 23459673]

Yersinia pestis (Plague)

  1. Hsu JL. A brief history of vaccines: smallpox to the present South Dakota medicine : the journal of the South Dakota State Medical Association Spec no:33-37 2013 [PMID: 23444589]

Click HERE to see the publications in the last month.